Incomplete reporting of recruitment information in clinical trials of biologic agents for the treatment of rheumatoid arthritis: A review

Arthritis Care and Research

Volumn 64, Issue 10, 2012, Pages 1611-1616

  Simsek, Ismail ^a   Yazici, Yusuf ^b  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ADALIMUMAB; BIOLOGICAL PRODUCT; CERTOLIZUMAB PEGOL; ETANERCEPT; GOLIMUMAB; INFLIXIMAB; RITUXIMAB; TOCILIZUMAB;

DATA EXTRACTION; HUMAN; MEDLINE; PATIENT INFORMATION; PATIENT PARTICIPATION; PATIENT SELECTION; PUBLICATION; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHEUMATOID ARTHRITIS; STATISTICAL ANALYSIS;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL AGENTS; CLINICAL TRIALS AS TOPIC; HUMANS; PATIENT SELECTION; RESEARCH DESIGN;

EID: 84869180310     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.21721     Document Type: Review

References (11)

1. Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Evidence based medicine: how to practice and teach EBM. Edinburgh (Scotland): Churchill Livingstone; 2000.
2. Rothwell PM. External validity of randomised controlled trials: "to whom do the results of this trial apply?" Lancet 2005; 365: 82-93. (Pubitemid 40082150)
3. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomised trials. Lancet 2001; 357: 1191-4. (Pubitemid 32378696)
4. Schulz KF, Altman DG, Moher D, and the CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 2010; 63: 834-40.
5. Gross CP, Mallory R, Heiat A, Krumholz HM. Reporting the recruitment process in clinical trials: who are these patients and how did they get there? Ann Intern Med 2002; 137: 10-6. (Pubitemid 34705371)
6. Jones R, Jones RO, McCowan C, Montgomery AA, Fahey T. The external validity of published randomized controlled trials in primary care. BMC Fam Pract 2009; 10: 5.
7. Toerien M, Brookes ST, Metcalfe C, de Salis I, Tomlin Z, Peters TJ, et al. A review of reporting of participant recruitment and retention in RCTs in six major journals [abstract]. Trials 2009; 10: 52.
8. Hopewell S, Hirst A, Collins GS, Mallett S, Yu LM, Altman DG. Reporting of participant flow diagrams in published reports of randomized trials [abstract]. Trials 2011; 12: 253.
9. Sokka T, Pincus T. Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or American College of Rheumatology criteria for remission. J Rheumatol 2003; 30: 1138-46. (Pubitemid 36666333)
10. Sokka T, Pincus T. Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor-agents in rheumatoid arthritis. Arthritis Rheum 2003; 48: 313-8. (Pubitemid 36277997)
11. Joseph G, Dohan D. Diversity of participants in clinical trials in an academic medical center: the role of the 'Good Study Patient?' Cancer 2009; 115: 608-15.